Bentham Science Logo

Track Your Manuscript:

Clinical Cancer Drugs

Volume 8, 2 Issues, 2021
ISSN: 2212-6988 (Online)
ISSN: 2212-697X (Print)
This journal supports open access


Clinical Cancer Drugs, Volume 3 - Number 1

Prostate Cancer Molecular Background: The IGF-1Ec Story

, 3(1): 6 - 15

Armakolas Athanasios and Koutsilieris Michael

DOI: 10.2174/2212697X03666151203202720

Castration-resistant Prostate Cancer: The Targeting of Bone Microenvironment-related Survival Factors For Prostate Cancer Cells

, 3(1): 16 - 22

Dimitrios Karamanolakis, Athanasios Armakolas and Michael Koutsilieris

DOI: 10.2174/2212697X03666151203202934

Targeting Epigenome As An Innovative Pharmacological Strategy For Castration-resistant Prostate Cancer

, 3(1): 23 - 35

Lavinia Casati, Fabio Celotti and Valeria Sibilia

DOI: 10.2174/2212697X03666151207185452

Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer Development and Progression: Insight to Therapy

, 3(1): 36 - 62

Festuccia Claudio

DOI: 10.2174/2212697X0301160328201324

Medicinal Compound Celastrol As a Potential Clinical Anticancer Drug: Lessons Learned From Preclinical Studies

, 3(1): 63 - 73

Jianquan Wu, Chengcheng Hong, Hongjie Pan, Qingzhu Yang, Yu Mei, Q. Ping Dou and Huanjie Yang

DOI: 10.2174/2212697X03666160112001739


Giulio Francia
Department of Biological Sciences
The University of Texas
El Paso, TX
View Full Editorial Board

Journal History

Clinical Cancer Drugs was introduced in 2014 with the assistance of Dr. Giulio Francia, who is the current Editor-in-Chief serving since 2014.

Related Journals

Related eBooks

eBooks Catalog